Federal legislation aims to boost IVIG reimbursement

July 9, 2007

The Medicare IVIG Access Act of 2007, which seeks adequate reimbursement for intravenous immunoglobulin (IVIG) products and accompanying care for patients with primary immunodeficiency diseases (PIDDs) and other conditions.

Rep. Kevin Brady (R, Texas) has introduced H.R. 2914, the Medicare IVIG Access Act of 2007, which seeks adequate reimbursement for intravenous immunoglobulin (IVIG) products and accompanying care for patients with primary immunodeficiency diseases (PIDDs) and other conditions. The Immune Deficiency Foundation (IDF) has issued a press release applauding the legislation. IDF explained that because of recent reduced IVIG reimbursement to health providers, many patients needing the products are denied or given delayed treatment. IDF believes the legislation, if passed, would improve PIDD patients' health outcomes and quality of life.

To see more Hot off the Press news articles, click here.

To go to the Drug Topics homepage, click here.